BackAlibaba Health Information Technology Limited Overview

Alibaba Health Information Technology Limited Receivables

Latest receivables for ALBBY: $1.3B.

Get informed when a big investor buys or sells

+ Follow
Receivables
$1.26B
39.17% YoYΔ $-812.22M vs prior year quarter

Peer average

Loading

Alibaba Health Information Technology Limited Receivables History

Loading

Alibaba Health Information Technology Limited vs. peers: Receivables Comparison

Loading

Alibaba Health Information Technology Limited Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Alibaba Health Information Technology Limited (ALBBY) FAQ

Alibaba Health Information Technology Limited (ALBBY) currently reports a receivables of $1.3B as of March 2026. That compares with $2.1B in the prior-year period — down 39.2% year over year. Use the charts on this page to explore Alibaba Health Information Technology Limited's receivables history and peer comparisons.

Alibaba Health Information Technology Limited's receivables decreased from $2.1B to $1.3B — a 39.2% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Alibaba Health Information Technology Limited reported $1.3B in receivables as of March 2026. That compares with $2.1B in the prior-year period — down 39.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $1.3B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Alibaba Health Information Technology Limited, and consider following ALBBY for alerts when major investors trade the stock.

Alibaba Health Information Technology Limited is classified in the Healthcare sector. On receivables, it currently shows $1.3B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ALBBY with unrelated industries.